Business context and reporting period
Precision Optics Corporation, Inc. filed this Form 10-K for the fiscal year ended June 30, 2022, with fiscal 2021 as the comparable period. Although the request metadata says “2021 Q4,” this filing reports full-year FY2022, not a standalone quarter. The company designs and manufactures medical optical systems and components, provides engineering services, and resells specialized optics for medical, defense, and industrial customers. Lighthouse Imaging was acquired effective October 4, 2021; its results are included from the acquisition date.
Financial performance and liquidity
| Metric | FY2022 | FY2021 |
|---|---|---|
| Revenue | $15.68 million | $10.67 million |
| Gross profit / margin | $4.93 million / 31.4% | $3.43 million / 32.2% |
| Operating loss | $1.51 million | $0.91 million |
| Net loss | $928,416 | $102,835 |
| Operating cash flow | $(933,371) | $46,550 |
| Cash at year-end | $605,749 | $861,650 |
Revenue increased 46.9%, primarily from the Lighthouse acquisition. By category, engineering design services were $5.37 million, optical components $6.48 million, and medical-device products and assemblies $3.82 million. Gross profit rose 43.5%, but margin narrowed because of engineering project cost overruns, lower-than-target Lighthouse manufacturing margins, and reduced margin on a large recurring component product. SG&A increased 51.1% to $5.61 million, mainly reflecting Lighthouse, stock compensation, marketing, and additional administrative staff. R&D expense was $666,479.
Net loss widened despite a $742,084 gain from revaluing the Lighthouse earn-out liability; FY2021 included an $808,962 gain from forgiveness of a PPP bank note. The company reported working capital of approximately $1.92 million at June 30, 2022, versus $2.27 million a year earlier. Current liabilities were $4.59 million, including $905,113 of customer advances.
The Lighthouse acquisition was financed in part with a $2.6 million bank term loan and a $1.5 million common-stock placement. At year-end, term-loan principal was $2.35 million; the balance sheet reported $2.33 million of current and long-term debt after debt issuance costs. The loan is secured by company assets, bears interest at prime plus 1.5%, and requires a minimum 1.20:1 debt-service coverage ratio beginning in FY2023. A $500,000 revolving credit facility had no borrowings outstanding. Contractual commitments included approximately $559,000 of future operating lease payments and $169,000 of capital-lease payments. Open purchase-order commitments were approximately $1.56 million.
Material changes, outlook, and risks
- The Lighthouse acquisition added end-to-end medical visualization and electrical-engineering capabilities, but the company cautioned that expected benefits and customer growth are not assured. Pro forma results, assuming Lighthouse had been acquired earlier, were revenue of $17.12 million and net loss of $871,121 for FY2022; these unaudited figures are not necessarily indicative of actual results.
- The company said break-even performance depends on sufficient quarterly revenue, gross margins, cost control, and timely customer collections. It expected its development pipeline to expand and projects to convert to production orders, but provided no quantified guidance.
- Management cited ongoing exposure to COVID-related and other supply-chain disruption, customer order delays, pricing pressure, engineering overruns, fixed-price contract risk, and dependence on a limited number of suppliers for optical glass, CMOS sensors, and processing services. The company had more than 377 customers; its largest represented 9.4% of FY2022 revenue.
- Recurring losses and cash use create a potential need for additional capital. Equity issuances, including shares used for the acquisition, increased dilution; 2.714 million options were outstanding at year-end.
- Management concluded disclosure controls and internal control over financial reporting were not effective at June 30, 2022. The identified material weakness concerned inadequate verification of Lighthouse inventory quantities. The company reported conducting a physical count and described further remediation steps; investors should assess whether remediation was sustained.
- The independent auditor issued an unqualified opinion. Revenue recognition and the Lighthouse goodwill impairment assessment were critical audit matters. Goodwill was $8.82 million, including $8.14 million attributed to Lighthouse; management recorded no impairment, based on estimates including revenue growth and EBITDA margins.
- The Lighthouse earn-out included up to $1.5 million contingent on gross-margin targets. The company reversed the first $750,000 portion to other income after determining the minimum target would not be met; the second $750,000 portion remained a long-term liability.
Important facts for investors to verify
- Whether Lighthouse inventory controls and project margins improved after the year-end weaknesses and overruns.
- Whether revenue growth converts into better gross margins, operating results, and positive operating cash flow.
- Cash runway, debt-service covenant compliance, and access to additional financing if losses persist.
- Actual earn-out obligations and the assumptions supporting the $8.14 million Lighthouse goodwill balance.
- Potential dilution from outstanding options, equity plans, and future capital raises.